DiaMedica Therapeutics Inc
NASDAQ:DMAC
DiaMedica Therapeutics Inc
NASDAQ:DMAC
Price:
8.42
USD
2.31%
Market Closed
Market Cap:
$453.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
US |
|
Burley Minerals Ltd
ASX:BUR
|
AU |
|
Azuma House Co Ltd
F:8A9
|
JP |
Shareholder Yield
Current shareholder yield for DMAC is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
DMAC Price
DiaMedica Therapeutics Inc
DiaMedica Therapeutics Inc
Annual Price Range
8.42
52w Low
5.33
52w High
9.39
Price Metrics
| Average Annual Return | 33.13% |
| Standard Deviation of Annual Returns | 60.65% |
| Max Drawdown | -76% |
Shares Statistics
| Market Capitalization | 454.1m USD |
| Shares Outstanding | 53 880 000 |
| Percentage of Shares Shorted | 14.4% |
DMAC Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
DMAC's latest stock split occurred on Nov 15, 2018
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, DMAC traded at 0.266 per share. Afterward, the share price was about 5.2.
The adjusted shares began trading on Nov 15, 2018. This was the only stock split in DMAC's history.
Pre-Split Price
5.32
0.266
Post-Split Price
5.2
Before
After